These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30207910)

  • 41. Health Insurance and Coverage of Evidence-Based Care.
    Rosenbaum S
    Public Health Rep; 2017; 132(2):260-263. PubMed ID: 28135426
    [No Abstract]   [Full Text] [Related]  

  • 42. Disclosing Prescription-Drug Prices in Advertisements - Legal and Public Health Issues.
    Dusetzina SB; Mello MM
    N Engl J Med; 2018 Dec; 379(24):2290-2293. PubMed ID: 30428275
    [No Abstract]   [Full Text] [Related]  

  • 43. Confronting State Medicaid Drug Spending Pressures.
    Sachs RE; Donohue JM; Dusetzina SB
    JAMA; 2020 Nov; 324(18):1831-1832. PubMed ID: 33034613
    [No Abstract]   [Full Text] [Related]  

  • 44. Paying for drug approvals--who's using whom?
    Avorn J
    N Engl J Med; 2007 Apr; 356(17):1697-700. PubMed ID: 17435083
    [No Abstract]   [Full Text] [Related]  

  • 45. Don't forget the exclusion lists.
    Markenson AJ; Evans SB
    Provider; 2010 Dec; 36(12):43-5. PubMed ID: 21197914
    [No Abstract]   [Full Text] [Related]  

  • 46. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-28. PubMed ID: 21374839
    [No Abstract]   [Full Text] [Related]  

  • 47. Off-label marketing and the First Amendment.
    Boumil MM
    N Engl J Med; 2013 Jan; 368(2):103-5. PubMed ID: 23234470
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2010 Jan; ():1-31. PubMed ID: 20217914
    [No Abstract]   [Full Text] [Related]  

  • 49. Drug makers skirting law, Sen. Pryor says.
    Wagner L
    Mod Healthc; 1991 Jan; 21(4):14. PubMed ID: 10108753
    [No Abstract]   [Full Text] [Related]  

  • 50. Drug safety reform at the FDA--pendulum swing or systematic improvement?
    McClellan M
    N Engl J Med; 2007 Apr; 356(17):1700-2. PubMed ID: 17435081
    [No Abstract]   [Full Text] [Related]  

  • 51. Accelerated Approval and Expensive Drugs - A Challenging Combination.
    Gellad WF; Kesselheim AS
    N Engl J Med; 2017 May; 376(21):2001-2004. PubMed ID: 28538133
    [No Abstract]   [Full Text] [Related]  

  • 52. The FDA and deference lost: a self-inflicted wound or the product of a wounded agency? A response to Professor O'Reilly.
    Vladeck DC
    Cornell Law Rev; 2008 Jul; 93(5):981-1002. PubMed ID: 18618967
    [No Abstract]   [Full Text] [Related]  

  • 53. FDA to steer nanotech.
    Fox JL
    Nat Biotechnol; 2008 Oct; 26(10):1060. PubMed ID: 18846060
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmaceuticals and medical devices: FDA oversight. Issue brief.
    Thomson Reuters/West
    Issue Brief Health Policy Track Serv; 2011 Jan; ():1-39. PubMed ID: 21374841
    [No Abstract]   [Full Text] [Related]  

  • 55. Bush tails follow-ons.
    Fox J
    Nat Biotechnol; 2008 Apr; 26(4):366. PubMed ID: 18392007
    [No Abstract]   [Full Text] [Related]  

  • 56. Pharmaceuticals: Medicare Modernization Act.
    Hilyard K; Howe WC
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-28. PubMed ID: 17361467
    [No Abstract]   [Full Text] [Related]  

  • 57. A cheat sheet to navigate the complex maze of exclusivities in the United States.
    Peng B; Tomas MC
    Pharm Pat Anal; 2014 Jul; 3(4):339-43. PubMed ID: 25291306
    [No Abstract]   [Full Text] [Related]  

  • 58. An Incomplete Prescription: President Trump's Plan to Address High Drug Prices.
    Sarpatwari A; Avorn J; Kesselheim AS
    JAMA; 2018 Jun; 319(23):2373-2374. PubMed ID: 29800027
    [No Abstract]   [Full Text] [Related]  

  • 59. The ongoing regulation of generic drugs.
    Frank RG
    N Engl J Med; 2007 Nov; 357(20):1993-6. PubMed ID: 18003956
    [No Abstract]   [Full Text] [Related]  

  • 60. CMS: Medicare drug formularies to cover most HIV drugs.
    AIDS Policy Law; 2005 Aug; 20(15):2. PubMed ID: 16136681
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.